Gain access to exclusive preclinical content.
Complete the form below. We'll assign a user name and password, then send you a link. Thanks!

Get Access Register

EXCLUSIVE PRECLINICAL CONTENT.
You must log in to access content on this page. Or click here to request access.
Niraparib, an FDA-Approved Poly-(ADP-Ribose) Polymerase (PARP) Inhibitor Is Renoprotective against Cisplatin Nephrotoxicity in Ovarian Tumor-Bearing Mice

Mira Noh, Amritha Kannan, Babu J. Padanilam. ASN Abstract supplement J Am Soc Nephrol 35: 2024 TH-PO1116.